MEDIPOST Co., Ltd. (KOSDAQ:078160)

South Korea flag South Korea · Delayed Price · Currency is KRW
13,480
-310 (-2.25%)
Oct 10, 2025, 3:30 PM KST
-2.25%
Market Cap459.65B
Revenue (ttm)72.17B
Net Income (ttm)-99.09B
Shares Out34.10M
EPS (ttm)-2,906.00
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume94,723
Average Volume189,230
Open13,690
Previous Close13,790
Day's Range13,100 - 13,690
52-Week Range5,580 - 15,790
Beta0.66
RSI54.33
Earnings DateNov 13, 2025

About MEDIPOST

MEDIPOST Co., Ltd. engages in the cord blood bank business in South Korea and internationally. The company operates through three divisions: Cord Blood Bank, Stem Cell Therapy, and Health Functional Food. It operates cord blood bank under the CELLTREE name. The company also offers CARTISTEM for the treatment of repetitive and/or traumatic cartilage degeneration, including degenerative osteoarthritis. In addition, it is developing stem cell products, such as PNEUMOSTEM for the preventative treatment of bronchopulmonary dysplasia. Further, the co... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Employees 322
Stock Exchange KOSDAQ
Ticker Symbol 078160
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.